Navigating challenges and charting the future of primary packaging for parenteral pharmaceuticals

Published: 12-Dec-2024

Administering parenteral medications, a cornerstone of contemporary medical practice, entails injecting the drug either beneath the skin or directly into the circulatory system, reports Anna Malori, Head of Product Management at Bormioli Pharma

You need to be a subscriber to read this article.
Click here to find out more.

This delivery mechanism is frequently chosen for its swift action, its capacity to deliver orally ineffective medications, its efficacy in urgent interventions and its ability to provide essential nutrients to patients who are unable to consume food normally.

Parenteral pharmaceuticals primarily encompass injectables — therapeutic agents administered by healthcare practitioners in clinical settings — such as vaccines, intravenous infusions and infusionals, which are supplemental fluids used as adjuncts to these treatments.

The packaging system for these vital medications represents a sophisticated feat of engineering, comprising the primary packaging itself — typically a vial or bottle — a rubber stopper and a standard or tear-off aluminium seal.

These vials are crafted from glass with diverse material specifications, manufacturing techniques and attributes that can be tailored to the specific properties and demands of the drugs.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

Relevant companies

You may also like